Jason Spacek

Jason Spacek serves as the Chief Commercial Officer at Afton Scientific, LLC, since March 2025. Previously, Jason held multiple leadership positions at Catalent Pharma Solutions, including Vice President roles in Business Development and Drug Product for North America and Vice President of Commercial Operations for Biologics. Jason’s extensive experience also includes commercial leadership at Alcami Corporation and various positions at Lonza, contributing to significant growth and strategic development in cell and gene therapy sectors. Jason holds a Bachelor of Science in Microbiology from the University of Maryland and a Master of Science in Cell and Molecular Biology from Towson University.